v3.26.3
CONDENSED CONSOLIDATED STATEMENTS OF CHANGES IN EQUITY - USD ($)
$ in Thousands
Total
Total shareholders’ equity
Common Stock
Accumulated Deficit
Accumulated other comprehensive income (loss)
Non-controlling interests
Beginning balance ( in shares) at Dec. 31, 2024     198,667,000      
Beginning balance at Dec. 31, 2024 $ 531,677 $ 527,794 $ 937,889 $ (404,023) $ (6,072) $ 3,883
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (26,324) (26,297)   (26,297)   (27)
Other comprehensive income (loss) (597) (597)     (597)  
Shares issued for cash by at-the-market offering (in shares)     15,808,000      
Shares issued under the at-the-market offering program 79,695 79,695 $ 79,695      
Share issuance cost (2,072) (2,072) (2,072)      
Share-based compensation 2,832 2,832 $ 2,832      
Common shares issued upon vesting of restricted stock units, net of shares withheld for income taxes (in shares)     293,000      
Shares issued upon vesting of restricted stock units, net of shares withheld for income taxes (664) (664) $ (664)      
Shares issued for exercise of stock options (in shares)     70,000      
Shares issued for exercise of stock options 123 123 $ 123      
Contribution to non-controlling interest 759         759
Ending balance (in shares) at Mar. 31, 2025     214,838,000      
Ending balance at Mar. 31, 2025 585,429 580,814 $ 1,017,803 (430,320) (6,669) 4,615
Beginning balance ( in shares) at Dec. 31, 2024     198,667,000      
Beginning balance at Dec. 31, 2024 531,677 527,794 $ 937,889 (404,023) (6,072) 3,883
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (65,169)          
Other comprehensive income (loss) 3,695          
Ending balance (in shares) at Sep. 30, 2025     236,866,000      
Ending balance at Sep. 30, 2025 707,563 703,245 $ 1,174,490 (468,868) (2,377) 4,318
Beginning balance ( in shares) at Mar. 31, 2025     214,838,000      
Beginning balance at Mar. 31, 2025 585,429 580,814 $ 1,017,803 (430,320) (6,669) 4,615
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (21,840) (21,812)   (21,812)   (28)
Other comprehensive income (loss) 3,688 3,688     3,688  
Shares issued for cash by at-the-market offering (in shares)     14,585,000      
Shares issued under the at-the-market offering program 76,313 76,313 $ 76,313      
Share issuance cost (2,057) (2,057) (2,057)      
Share-based compensation   3,202 $ 3,202      
Common shares issued for exercise of stock appreciation rights, net of shares withheld for income taxes (in shares)     0      
Shares issued for exercise of stock options (in shares)     2,000      
Shares issued for exercise of stock options   34 $ 34      
Ending balance (in shares) at Jun. 30, 2025     229,425,000      
Ending balance at Jun. 30, 2025 644,769 640,182 $ 1,095,295 (452,132) (2,981) 4,587
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (17,005) (16,736)   (16,736)   (269)
Other Comprehensive Income (Loss) before Reclassifications, Tax   604     604  
Other comprehensive income (loss) 604          
Shares issued for cash by at-the-market offering (in shares)     7,240,000      
Shares issued under the at-the-market offering program 77,283 77,283 $ 77,283      
Share issuance cost   (2,319) (2,319)      
Share-based compensation 3,406 3,406 $ 3,406      
Shares issued for the vesting of restricted stock units (in shares)     32,000      
Common shares issued for exercise of stock appreciation rights, net of shares withheld for income taxes (in shares)     169,000      
Shares issued upon vesting of restricted stock units, net of shares withheld for income taxes (122) (122) $ (122)      
Shares issued for exercise of stock options 947 947 $ 947      
Ending balance (in shares) at Sep. 30, 2025     236,866,000      
Ending balance at Sep. 30, 2025 707,563 703,245 $ 1,174,490 (468,868) (2,377) 4,318
Beginning balance at Dec. 31, 2025 682,570 678,405 $ 1,170,958 (489,657) (2,896) 4,165
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (10,960) (10,844)   (10,844)   (116)
Other comprehensive income (loss) 2,369 2,369     2,369  
Shares issued for cash by at-the-market offering (in shares)     3,042,000      
Shares issued under the at-the-market offering program 54,399 54,399 $ 54,399      
Share issuance cost (1,632) (1,632) (1,632)      
Share-based compensation 3,648 3,648 $ 3,648      
Common shares issued for exercise of stock appreciation rights, net of shares withheld for income taxes (in shares)     16,000      
Shares issued for exercise of stock appreciation rights, net of shares withheld for income taxes (156) (156) $ (156)      
Common shares issued upon vesting of restricted stock units, net of shares withheld for income taxes (in shares)     662,000      
Shares issued upon vesting of restricted stock units, net of shares withheld for income taxes (5,023) (5,023) $ (5,023)      
Shares issued for exercise of stock options (in shares)     324,000      
Shares issued for exercise of stock options 2,101 2,101 $ 2,101      
Ending balance (in shares) at Mar. 31, 2026     244,410,000      
Ending balance at Mar. 31, 2026 727,316 723,267 $ 1,224,295 (500,501) (527) 4,049
Beginning balance at Dec. 31, 2025 682,570 678,405 1,170,958 (489,657) (2,896) 4,165
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (96,933)          
Other comprehensive income (loss) $ 4,077          
Shares issued for exercise of stock options (in shares) 438,866          
Ending balance at Sep. 30, 2026 $ 966,922 962,058 1,546,962 (586,085) 1,181 4,864
Beginning balance at Mar. 31, 2026 727,316 723,267 $ 1,224,295 (500,501) (527) 4,049
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (33,603) (33,378)   (33,378)   (225)
Other comprehensive income (loss)   697     697  
Shares issued for cash by at-the-market offering (in shares)     5,333,000      
Shares issued under the at-the-market offering program 103,410 103,410 $ 103,410      
Share issuance cost   (3,102) (3,102)      
Share-based compensation   3,899 $ 3,899      
Shares issued for the vesting of restricted stock units (in shares)     83,000      
Common shares issued for exercise of stock appreciation rights, net of shares withheld for income taxes (in shares)     1,000      
Shares issued for exercise of stock appreciation rights, net of shares withheld for income taxes (515) (515) $ (515)      
Shares issued upon vesting of restricted stock units, net of shares withheld for income taxes (2,311) (2,311) $ (2,311)      
Shares issued for exercise of stock options (in shares)     92,000      
Shares issued for exercise of stock options   603 $ 603      
Contribution to non-controlling interest 404         404
Ending balance (in shares) at Jun. 30, 2026     249,919,000      
Ending balance at Jun. 30, 2026 796,798 792,570 $ 1,326,279 (533,879) 170 4,228
Increase (Decrease) in Stockholders' Equity [Roll Forward]            
Net loss (52,370) (52,206)   (52,206)   (164)
Other comprehensive income (loss) 1,011 1,011     1,011  
Shares issued for ASM acquisition (in shares)     14,809,000      
Shares issued for ASM acquisition 218,042 217,242 $ 217,242     800
Share-based compensation 3,653 3,653 $ 3,653      
Shares issued for the vesting of restricted stock units (in shares)     77,000      
Common shares issued for exercise of stock appreciation rights, net of shares withheld for income taxes (in shares)     1,000      
Shares issued for exercise of stock appreciation rights, net of shares withheld for income taxes (29) (29) $ (29)      
Shares issued upon vesting of restricted stock units, net of shares withheld for income taxes (187) (187) $ (187)      
Shares issued for exercise of stock options (in shares)     22,000      
Shares issued for exercise of stock options   4 $ 4      
Ending balance at Sep. 30, 2026 $ 966,922 $ 962,058 $ 1,546,962 $ (586,085) $ 1,181 $ 4,864